ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

MR: Mindray Medical Intl Ltd - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

MINDRAY MEDICAL INTL LTD (NYSE)
MR	29.14	N/A	(N/A%)	Vol. 0	N/A ET

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has twenty nine local sales and services offices in China, as well as sales and services offices in Boston, Istanbul, London and Vancouver.

General Information

MINDRAY MEDICAL

- -, - - Phone: - Fax: - Web: - Email: None

Industry	MED INSTRUMENTS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	03/10/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	29.14
52 Week High	34.49
52 Week Low	15.00
Beta	1.26
20 Day Moving Average	906,671.13
Target Price Consensus	33.38

% Price Change
4 Week	-12.19
12 Week	-8.29
YTD	60.50

% Price Change Relative to S&P 500
4 Week	-13.14
12 Week	-13.53
YTD	32.83

Share Information
Shares Outstanding (millions)	75.53
Market Capitalization (millions)	2,182.03
Short Ratio	12.80
Last Split Date	N/A

Dividend Information
Dividend Yield	0.69%
Annual Dividend	$0.20
Payout Ratio	0.17
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.30
Current Year EPS Consensus Estimate	1.15
Estimated Long-Term EPS Growth Rate	27.30
Next EPS Report Date	03/10/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.00
30 Days Ago	2.00
60 Days Ago	2.00
90 Days Ago	2.00

Fundamental Ratios

P/E
Current FY Estimate:	25.15
Trailing 12 Months:	24.69
PEG Ratio	0.92

EPS Growth
vs. Previous Year	11.11%
vs. Previous Quarter	-3.23%

Sales Growth
vs. Previous Year	3.14%
vs. Previous Quarter:	-5.58%

Price Ratios
Price/Book	3.65
Price/Cash Flow	14.91
Price / Sales	3.56

ROE
09/30/09	25.08
06/30/09	26.02
03/31/09	26.43

ROA
09/30/09	16.06
06/30/09	16.47
03/31/09	16.63

Current Ratio
09/30/09	1.98
06/30/09	1.53
03/31/09	1.52

Quick Ratio
09/30/09	1.65
06/30/09	1.32
03/31/09	1.32

Operating Margin
09/30/09	21.47
06/30/09	21.07
03/31/09	21.18

Net Margin
09/30/09	25.08
06/30/09	21.85
03/31/09	20.83

Pre-Tax Margin
09/30/09	25.08
06/30/09	21.85
03/31/09	20.83

Book Value
09/30/09	7.91
06/30/09	6.59
03/31/09	6.71

Inventory Turnover
09/30/09	4.33
06/30/09	4.50
03/31/09	4.44

Debt-to-Equity
09/30/09	0.11
06/30/09	-
03/31/09	0.00

Debt to Capital
09/30/09	9.95
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research